KeyBanc maintains Overweight rating on West Pharmaceutical stock ByBy FinMar NewsJuly 27, 2025KeyBanc maintains Overweight rating on West Pharmaceutical stock Read More: KeyBanc maintains Overweight rating on West Pharmaceutical stock By
Trump health care plan likely good for pharmaceutical companiesBy FinMar NewsJanuary 26, 2025U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November…